ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').


Date Title Topic
08 Oct 2016 ESMO 2016 Press Release: Phase I Study of Novel Anti-Cancer Drug Uses Tumour mRNA Expression to Identify Responders Anticancer agents & Biologic therapy
07 Oct 2016 ESMO 2016 Press Release: Thousands of Melanoma Patients in Europe Have no Access to New Life Saving Drugs Melanoma and other skin tumours
07 Oct 2016 ESMO 2016 Press Release: High response rate in phase I/II paediatric brain cancer trial sets stage for combination therapy with higher response and lower toxicity Central nervous system malignancies
07 Oct 2016 ESMO 2016 Press Release: Neoadjuvant Immunotherapy Prior to Surgery is Safe and Feasible in Early Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
06 Oct 2016 ESMO 2016 Press Release: Improving Cancer Screening Participation Should be a Priority Epidemiology/Etiology/Cancer Prevention
05 Oct 2016 ESMO 2016 Press Release: Reporting of Adverse Events in Targeted Therapy and Immunotherapy Trials is “Suboptimal” Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
04 Oct 2016 ESMO 2016 Press Release: Impact of Cognitive Functions on Oral Cancer Therapies
30 Sep 2016 Press Release: New Edition of ESMO/ASCO Global Curriculum in Medical Oncology – Setting Standards for Modern Training
29 Sep 2016 ESMO 2016 Press Release: Ki67 May Help Avoid Sentinel Lymph Node Biopsy in Some Patients Breast cancer - Basic science
28 Sep 2016 Media Alert: ESMO 2016 Poster Abstracts Published Online Today
23 Sep 2016 Press Release: Precision Medicine Trial First of its Kind to Show Benefit to Patients
21 Sep 2016 ESMO 2016 Media Alert: ESMO Announces Press Programme Presenting Latest Cancer Research
19 Sep 2016 Press Release: Launch of First eUpdate Integrating Breakthroughs in ESMO Clinical Practice Guidelines
06 Sep 2016 Press Release: ESMO Rewards Outstanding Oncologists
26 Jul 2016 Press Release: ESMO Publishes Results of European Consortium Study on the Availability of Anti-neoplastic Medicines